| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.22 | 0.0005 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0008 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.001 |